EE25 Economic Benefit of Faricimab Compared to Aflibercept 8mg in Treating Patients with Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema in the United States
| Autor: | Tabano, D, El, Moustaid F, Rosettie, KL, Ko, S, Meer, E, Brodie, FL |
|---|---|
| Zdroj: | In Value in Health June 2024 27(6) Supplement:S61-S61 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect